Navigation Links
Cardiome To Hold Conference Call
Date:7/13/2008

n involve known and unknown risks, uncertainties and other factors that may cause our actual results, events or developments, or industry results, to be materially different from any future results, events or developments expressed or implied by such forward-looking statements or information. Such factors include, among others, our stage of development, lack of product revenues, additional capital requirements, risk associated with the completion of clinical trials and obtaining regulatory approval to market our products, the ability to protect our intellectual property, dependence on collaborative partners and the prospects for negotiating additional corporate collaborations or licensing arrangements and their timing. Specifically, certain risks and uncertainties that could cause such actual events or results expressed or implied by such forward-looking statements and information to differ materially from any future events or results expressed or implied by such statements and information include, but are not limited to, the risks and uncertainties that: we may not be able to successfully develop and obtain regulatory approval for vernakalant (iv) or vernakalant (oral) in the treatment of atrial fibrillation or any other current or future products in our targeted indications; our future operating results are uncertain and likely to fluctuate; we may not be able to raise additional capital; we may not be successful in establishing additional corporate collaborations or licensing arrangements; we may not be able to establish marketing and sales capabilities and the costs of launching our products may be greater than anticipated; we rely on third parties for the continued supply and manufacture of vernakalant (iv) and vernakalant (oral) and we have no experience in commercial manufacturing; we may face unknown risks related to intellectual property matters; we face increased competition from pharmaceutical and biotechnology companies; and other factors as described in
'/>"/>
SOURCE Cardiome Pharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Cardiome Reports First Quarter Results
2. Cardiome To Release 2008 First Quarter Results
3. Cardiome To Release 2007 Results
4. Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant and Engages Merrill Lynch as Strategic Advisor
5. Cardiome And Astellas Announce Regulatory Update
6. Cardiome to Hold Investor Update Call
7. Cardiome Updates Guidance
8. Cardiome Initiates Phase 1 Study for GED-aPC
9. Cardiome To Release Third Quarter Results
10. Cardiome to Present at CIBC Conference
11. Cardiome to Present at ThinkEquity Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... Seattle, WA (PRWEB) , ... July 31, 2015 , ... ... rapidly transforming the way we treat aging diseases. , BioViva announces it has ... to treat patients with Alzheimer’s Disease (AD) and find a cure. MaxLife will grant ...
(Date:7/31/2015)... ... 2015 , ... The Heart Fit Clinic has increased a patient's fitness level ... of 150 beats versus 100 beats, this is a big deal," says Diamond Fernandes, ... back to patients with heart disease," he adds. People with angina are able to ...
(Date:7/31/2015)... ... July 31, 2015 , ... Patients with higher levels ... a study published today in Nature Communications and led by researchers from the Icahn ... that variations in the gene RTN1 led to greater production of the related RNT1 ...
(Date:7/31/2015)... ... ... Indosoft, Inc., is pleased to announce a major update to its agent interface ... ACD system for Asterisk-based call centers . The new features make it easier ... agent only when wanted, and allows for validation of data as the agent enters ...
(Date:7/31/2015)... ... 2015 , ... According to WFLA on July 16th, Sarasota has ... eventual overdoses. Thricefold deaths have held steady over the last “couple of months” according ... epidemic, which was spurred by the crackdown of prescription painkillers. Many users who were ...
Breaking Medicine News(10 mins):Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 2Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 3Health News:Heart Fit Clinic Helps Patient Increase Fitness Level with External Counterpulsation 2Health News:Mount Sinai Researchers Find Key Gene Drives Kidney Disease Severity 2Health News:Mount Sinai Researchers Find Key Gene Drives Kidney Disease Severity 3Health News:Q-Suite 5.9 Adds Validation Tools to Call Center Software Agent Screen 2Health News:Sarasota Sufferers Increased Heroin Overdoses and Deaths 2Health News:Sarasota Sufferers Increased Heroin Overdoses and Deaths 3
... 15 The World Health Organization has increased the pandemic alert ... flu, the first time it has been raised to this level ... themselves, but need not be fearful. The outbreak is considered ... that influenza A (H1N1) is necessarily causing more serious infections, or ...
... ... Staffing Solutions , ... Alpharetta, GA (Vocus) June 14, 2009 -- "Thomas McKeever has been ... marketing thrust--introducing a more streamlined approach to physician staffing at prominent hospitals and ...
... generate infection-fighting proteins called antibodies that either block infection ... disease. Attempts to create a vaccine that induces antibodies ... far been unsuccessful. But several recent studies suggest promising ... HIV vaccine, according to John R. Mascola, M.D., deputy ...
... information exchange , , TORONTO, June 14 ... Toronto this week, Siemens Healthcare will highlight Symbia.net*, the ... for anytime, anywhere processing and reading. Show attendees are ... (#1024). , , (Photo: ...
... can occur, , SUNDAY, June 14 (HealthDay News) -- The ... attention to the issue of brain injury and raised important ... or a loved one. , Richardson died hours after taking ... picked herself up from the fall and refused medical attention, ...
... January to May 2009 sees ... , ... the chairman of MYA Cosmetic Surgery Ltd. and former owner of Transform Medical Group, ... eyelid surgery. John Ryan, 59, has decided to have the procedure which he feels will make ...
Cached Medicine News:Health News:As World Health Organization Raises Influenza A (H1N1) Pandemic Alert to Level Six, Hygiene Council Recommends Simple Steps to Help Protect Families from Illness 2Health News:As World Health Organization Raises Influenza A (H1N1) Pandemic Alert to Level Six, Hygiene Council Recommends Simple Steps to Help Protect Families from Illness 3Health News:Thomas McKeever to Spearhead Jackson & Coker's National Accounts Division 2Health News:Thomas McKeever to Spearhead Jackson & Coker's National Accounts Division 3Health News:NIAID media availability: New strategy proposed for designing antibody-based HIV vaccine 2Health News:Symbia.net - Hotspot for Remote Access 2Health News:Symbia.net - Hotspot for Remote Access 3Health News:For Every Blow to the Head, Quick Action Is Urged 2Health News:For Every Blow to the Head, Quick Action Is Urged 3Health News:Cosmetic Surgery Pioneer Goes Under the Knife 2Health News:Cosmetic Surgery Pioneer Goes Under the Knife 3
(Date:7/31/2015)... 2015 The Physician-Patient Alliance for Health ... 28, 2015, "Surviving Your Hospital Stay: Physician-Patient Alliance ... Safety." A sentence was omitted from ... "PPAHS is a member of the National Coalition ... information on the National Coalition to Promote Continuous Monitoring ...
(Date:7/31/2015)... Egalet Corporation (Nasdaq: EGLT ) ... on developing, manufacturing and marketing innovative pain treatments, ... underwritten public offering of 7,666,667 shares of its ... $11.25 per share. The shares of common stock ... the exercise in full by the underwriters of ...
(Date:7/31/2015)... , July 31, 2015 ... for video, data and cloud computing operators has ... leading pharma giant for Internet of Things (IoT) ... applications offered on subscription model.      ... giant is striving for business innovations to make ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2
... 21 Accuray Incorporated (Nasdaq: ARAY ), a ... plans to establish an America,s region thereby establishing regionalized ... , The formation of this new Americas region, ... and Japan, gives each region control of revenue and ...
... , WARSAW, Ind., Oct. 21 Symmetry Medical Inc. (NYSE: ... the global orthopaedic device industry and other medical markets, announced ... for the period ending October 3, 2009 before the market ... an accompanying conference call at 8:00 a.m. ET on Thursday, ...
Cached Medicine Technology:Accuray Announces Regionalized Management Strategy for Americas 2Accuray Announces Regionalized Management Strategy for Americas 3Symmetry Medical to Report Third Quarter 2009 Financial Results on November 5, 2009 2
Introducing the Guidant HEARTSTRING Proximal Seal System. A surgically intuitive system that meets the challenge of clampless hemostasis with a design that is elegant in its simplicity and profound i...
... The Nidek's ophthalmic Nd: YAG laser YC-1600 ... system of superb versatility and clinical performance., ... Laser (1064nm),, Lightweight Model ,Further weight ... convenient setting in your office.,, Aiming ...
... system, developed by Given Imaging of Israel, is ... a grape. Weighing in at only four grams, ... LED lights, battery and radio transmitter coated by ... digestive enzymes. Internal gastric images are transmitted to ...
... catheter-free Bravo pH Monitoring System ... testing is done. Bravo allows ... diet and activities during pH ... catheter-free, the added convenience for ...
Medicine Products: